Atlantic Health Strategies logo
LinkedIn icon
Contact Us

Atlantic Health Strategies

X-twitter Linkedin
Atlantic Health Strategies Logo

MHPAEA Final Rule, Behavioral Health M&A, and Federal Enforcement in 2024: What Operators Needed to Know

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

Contact Us

The short answer for operators

Three federal events in the fall of 2024 reshaped how behavioral health operators had to run payer readiness, deal prep, and compliance at the same time. The Departments of Labor, HHS, and Treasury issued the MHPAEA Final Rule on September 9, 2024. The DOJ resolved a $19.85 million False Claims Act case against Acadia Healthcare on September 26, 2024. And Mertz Taggart reported the slowest behavioral health M&A quarter since the onset of COVID.

If you ran a treatment center in Florida, Tennessee, Ohio, or anywhere else with meaningful commercial payer mix, all three of these landed on your desk simultaneously. Below is what my team at Atlantic Health Strategies told our client operators to actually do about it, and where the picture stood a few months later once the enforcement landscape shifted again.

The MHPAEA Final Rule: NQTL comparative analyses stopped being optional theater

The Departments finalized the 2024 Final Rule on September 9, 2024. It became effective November 22, 2024, with staggered applicability dates for plan years starting on or after January 1, 2025 and January 1, 2026. The rule targeted exactly the practices behavioral health providers have fought for years.

What matters to a treatment center operator is what plans had to prove. The rule required plans to evaluate standards related to network composition, out-of-network reimbursement rates, and medical management and prior authorization NQTLs, and it prohibited plans and issuers from using discriminatory information, evidence, sources, or standards that systematically disfavor access to MH/SUD benefits.

HHS was blunt about the reason it acted. In its September 9, 2024 announcement, the Department said the rules require plans and issuers to “collect and evaluate data related to the nonquantitative treatment limitations they place on mental health and substance use disorder care and make changes if the data shows they are providing insufficient access.” Translation for operators: your payers had a documentation problem, and your denial data was now evidence.

What we told Florida and Tennessee operators to do in Q4 2024: pull twelve months of denial and prior-auth data by level of care under the ASAM Criteria 4th Edition. Segment residential withdrawal management (Level 3.7), residential, PHP (Level 2.5, which is outpatient), and IOP separately. When your managed care contracting team walks into renewal season, that dataset is the argument that moves rates.

A note on what happened next. On May 15, 2025, the Departments announced they would not enforce the 2024 Final Rule based on a failure to comply that occurs prior to a final decision in the ERIC litigation, plus an additional 18 months. Do not stand down. The DOL’s own July 2023 MHPAEA Comparative Analysis Report to Congress found that “none of the comparative analyses initially submitted were sufficient to demonstrate compliance,” and the underlying CAA-21 statutory requirement to perform and produce a comparative analysis on request remains in force.

M&A in Q3 2024: fewer deals, tighter diligence, patient buyers

The Q3 2024 story was not a collapse. It was a selection event. Mertz Taggart reported that deal volume across the behavioral healthcare sector dropped in Q3 2024 to levels not seen since the onset of the COVID-19 pandemic, with just 31 behavioral healthcare transactions announced even when factoring in venture capital growth deals. On the mental health side, 19 deals were announced. Addiction treatment came in at six, down from 11 in each of the two prior quarters.

Buyer psychology mattered more than the count. Mertz Taggart Managing Partner Kevin Taggart put it plainly: “Buyers are becoming much more discerning.” He also noted that strategic buyers on both the mental health and addiction sides were sitting on the sidelines, some still digesting acquisitions from prior years.

Here is what we watched happen in diligence rooms in Florida and Texas in Q3 and Q4 2024. Buyers wanted three things they used to skim: a real NQTL/denial dataset, clean documentation of ASAM level-of-care determinations under the 4th Edition, and a compliance program with named ownership, not a binder. Founders who produced those in 72 hours moved to LOI. Founders who couldn’t dropped a full turn of EBITDA in valuation. Sometimes more.

Federal enforcement: Acadia's $19.85M and the 2024 Takedown set the compliance bar

The Acadia settlement is the one every behavioral health board should read. On September 26, 2024, the DOJ announced that Acadia Healthcare would pay $19.85 million to the U.S. And several state governments to resolve allegations that it knowingly billed for medically unnecessary behavioral health services and endangered patients between 2014 and 2017.

The specific allegations map directly to surveyor and SIU audit exposure. The DOJ alleged that Acadia admitted Medicare, Medicaid and TRICARE beneficiaries who were not eligible for inpatient treatment and did not discharge them when they were no longer in need of care, leading to “improper and excessive lengths of stay,” and that Acadia knowingly failed to properly staff its facilities and/or train and supervise its staff, “which resulted in assaults, elopements, suicides and other harm resulting from these staffing failures.”

The states shared meaningfully in the recovery. Acadia agreed to pay $16.66 million to the U.S. Government for false billing under federal health programs, and $3.19 million to Florida, Georgia, Michigan and Nevada to resolve their state law claims. Read that split twice. State Medicaid Fraud Control Units in four states are now inside a case built around medical necessity, level-of-care assignment, staffing, and length of stay. That is the exact chart a surveyor pulls.

Zoom out to the federal picture. The June 27, 2024 National Health Care Fraud Enforcement Action charged 193 defendants across 32 federal districts in schemes involving approximately $2.75 billion in intended losses and $1.6 billion in actual losses. The government seized $231 million in cash, gold, luxury vehicles, and other assets in connection with the takedown.

Addiction treatment was named as a priority. And the case selection method itself is worth noting. Attorney General Garland stated at the June 2024 press conference that one of the four fundamental principles guiding DOJ’s health care fraud efforts is “using data analytics to keep pace with constantly evolving fraud schemes,” and DOJ specifically credited data analytics with driving the amniotic skin graft, stimulant distribution, and genetic testing investigations. If your billing pattern is an outlier, DOJ finds you before a whistleblower does.

The 90-day operator playbook we ran for clients

If you operated a treatment center in Ohio, Florida, or Tennessee in Q4 2024, here is what the AHS team put on the calendar with our clients.

  • Payer readiness file, 30 days. Pull 12 months of denials by level of care and payer. Map denial reasons to the NQTL categories called out in the Final Rule: prior authorization, concurrent review, network adequacy, out-of-network reimbursement. Operators use this file to press payers in managed care contracting and to defend the chart when a payer’s SIU audit lands.
  • Mock survey and EOC tour, 45 days. Focus surveyor attention on medical necessity documentation, ASAM 4th Edition level-of-care rationale, discharge planning, and staffing logs. Every finding the Acadia settlement referenced is a finding a surveyor can reach through a chart pull.
  • Compliance program refresh, 60 days. Named compliance officer with real authority. Board reporting cadence. Documented internal audit schedule. A functioning hotline. This is the difference between a $19.85 million settlement and a Corporate Integrity Agreement plus prosecution.
  • Deal readiness data room, 90 days. If you plan to sell or take capital, buyers now expect NQTL analytics, level-of-care documentation, and compliance program artifacts on day one of diligence. Founders who show up prepared close at premium multiples. Founders who don’t take price cuts they cannot recover.

None of this is theoretical. Every item on that list came from a real room, a real regulator question, or a real payer meeting between October 2024 and January 2025.

Frequently asked questions

Is the MHPAEA 2024 Final Rule still enforceable against health plans?

The 2024 Final Rule was issued September 9, 2024 and became effective November 22, 2024, with the earliest applicability date for plan years starting January 1, 2025. On May 15, 2025, the Departments of Labor, HHS, and Treasury announced they would not enforce the new portions of the 2024 Final Rule until 18 months after a final decision in the ERIC lawsuit. However, MHPAEA’s underlying statutory obligations, including the NQTL comparative analysis requirement Congress added in the Consolidated Appropriations Act, 2021, remain in full effect. Plans still must perform and produce a comparative analysis on request.

What did the Acadia Healthcare $19.85 million settlement actually cover?

On September 26, 2024, the DOJ announced Acadia Healthcare agreed to pay $19.85 million to resolve False Claims Act allegations that it billed Medicare, Medicaid, and TRICARE for medically unnecessary inpatient behavioral health services between 2014 and 2017. The allegations included admitting patients ineligible for inpatient treatment, failing to discharge patients when they no longer needed inpatient care, and staffing failures the DOJ said resulted in assaults, elopements, and suicides. Florida, Georgia, Michigan, and Nevada shared in $3.19 million of the settlement, with $16.66 million paid to the federal government.

How active was behavioral health M&A in Q3 2024?

According to Mertz Taggart, Q3 2024 saw 19 mental healthcare deals and six addiction treatment deals, with the addiction number down from 11 in each of the two prior quarters. Total behavioral healthcare transactions, including venture capital growth deals, totaled 31 in the quarter, which the firm described as levels not seen since the onset of the COVID-19 pandemic. Buyers were still active but became more selective, with heavier diligence on compliance programs, medical necessity documentation, and payer denial data.

How big was the DOJ’s 2024 National Health Care Fraud Enforcement Action?

HHS-OIG reported that the June 27, 2024 action resulted in criminal charges against 193 defendants, including 76 doctors, nurse practitioners, and other licensed medical professionals, across 32 federal districts, for schemes involving approximately $2.75 billion in intended losses and $1.6 billion in actual losses. The government seized approximately $231 million in cash, luxury vehicles, gold, and other assets in connection with the takedown. Addiction treatment was named as a priority area, and DOJ specifically credited its data analytics team with driving several of the investigations.

References

Request a Free Consultation

Scroll to Top